CCc1cc(Cc2cc(CC)c(NC(=O)C(=O)Cc3ccccn3)c(CC)c2Cl)c(Cl)c(CC)c1NC(=O)C(=O)Cc1ccccn1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?